Dhaka, Bangladesh (BBN) – The board of directors of ACME Laboratories has recommended 35 percent cash dividend for the year ended on June 30, 2016, said an official disclosure on Wednesday.
The final approval will come during the annual generation meeting (AGM) scheduled to be held on November 7 at 10:30am at PSC Convention Hall, Mirpur in Dhaka.
The record date for entitlement of cash dividend is on October 13.
The company has reported earnings per share (EPS) of BDT 6.55, net asset value (NAV) per share of BDT 77.34 and net operating cash flow per share (NOCFPS) of BDT 6.25 for the year ended on June 30, 2016 as against BDT 5.70, BDT 70.37 and BDT 6.50 respectively for the same period of the previous year.
There will be no price limit on the trading of the shares of the company today following its corporate declaration.
The country’s oldest pharmaceuticals company’s share price hovered between BDT 109.70 and BDT 112.80 on Tuesday, before closing at BDT 111.50 each, shedding 1.26 percent over the day before.
ACME Laboratories, which was listed on the stock exchanges in June this year, recommended the first dividend after listing.
ACME’s paid-up capital is BDT 2,116.02 million and authorised capital is BDT 5,000 million, while the total number of securities is 211,601,700.
The company’s total market cap stood at BDT 23,551.27 million as on Tuesday.
The sponsor-directors own 38.88 percent stake in the ACME, while institutional investors own 23.88 percent, foreign 0.73 percent and the general public 36.51 percent as on July 31, 2016, the DSE data showed.
BBN/AD/SR